Virtual Medicine Conference: dive into Medical Extended Reality

The Virtual Medicine Conference (VMed) was founded to accelerate the translation of immersive technologies into patient care. Over seven editions, it has grown from a niche workshop into a flagship symposium, drawing attendees from academic centers, hospitals and industry alike.

By zeroing in on Medical Extended Reality, VMed underscores how these tools go beyond entertainment, offering verifiable clinical benefits in diagnostics, therapy and professional training.

More than 330 attendees took part in this 7th edition, alongside 50+ international speakers and 20+ exhibiting companies, a sign of the field's growing maturity and momentum.

MXR is increasingly recognized for its potential to support both patients and practitioners. Throughout the 2025 VMed conference, attendees discovered real-world applications of immersive technology, including:

– therapeutic VR environments for anxiety, chronic pain, and post-stroke rehabilitation;

– AR-assisted surgical planning and guidance, overlaying imaging data onto the surgeon's field of view;

– VR-based training modules for clinicians, allowing for high-fidelity simulations in safe, controlled environments.

The diversity of use cases presented at vMed confirmed once again that these technologies are no longer experimental. They are already improving patient care across numerous disciplines. As demonstrated throughout the event, MXR will only thrive if it's clinically valuable, operationally feasible and emotionally meaningful.

vMed isn't just about showcasing the latest gear, it aims at building a sustainable path forward. This year, the program was structured around five key goals:

– Implement MXR in practice: share best practices and pragmatic tips for integrating immersive tech into workflows.

– Review evidence base: present peer‑reviewed data on safety, efficacy and long‑term outcomes.

– Discuss cost and reimbursement: analyze payer perspectives, cost‑effectiveness models and CPT coding strategies.

– Hear patient perspectives: feature firsthand accounts from individuals who have benefited from MXR therapies.

– Advance provider training: examine MXR's role in clinical simulation and ongoing professional education.

vMed 25 attracted a multidisciplinary audience, including:

– clinicians (neurologists, psychiatrists, surgeons) adopting MXR for direct patient care;

– researchers presenting trials on VR‑induced neuroplasticity and AR guidance systems;

– industry partners developing headsets, haptic feedback devices and software platforms;

– patient advocates and journalists ensuring user‑centric design and broad dissemination of MXR advances.

In this environment, bridges were built between science, care and design.